<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 34-year-old man with diffuse eosinophilic <z:hpo ids='HP_0100537'>fasciitis</z:hpo> and a hypocellular <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> underwent marrow transplantation from an HLA-identical brother </plain></SENT>
<SENT sid="1" pm="."><plain>Prompt hematopoietic reconstitution was observed, strongly suggesting that the marrow hypocellularity was caused by neither a serum inhibitory factor nor a microenvironmental disorder </plain></SENT>
<SENT sid="2" pm="."><plain>The patient died of disseminated <z:e sem="disease" ids="C0010823" disease_type="Disease or Syndrome" abbrv="">cytomegalovirus infection</z:e> too early to evaluate the impact of hematopoietic reconstitution on the eosinophilic <z:hpo ids='HP_0100537'>fasciitis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Nevertheless, marrow transplantation may offer a therapeutic option for those patients with this disorder who develop severe hematopoietic dysfunction and who have a suitable marrow donor </plain></SENT>
</text></document>